Trials / Unknown
UnknownNCT03297840
Change in Mindfulness in Borderline Personality Disorder
Change in Mindfulness in Borderline Personality Disorder After Dialectic-behavioural Therapy (DBT): A Pre-post-comparison
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Katharina Bachmann · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The current study aims to investigate the effect of dialectical behavioral therapy on mindfulness in patients with Borderline Personality Disorder. A treatment group will be compared to a waitlist control group.
Detailed description
Participants will be recruited from the Dialectical-Behavioral-Therapy (DBT) unit. DBT is a treatment approach that has been shown to be effective in the treatment of Borderline Personality Disorder. DBT integrates different psychotherapeutic interventions as well as Mindfulness Meditation exercises. Mindfulness is a meditation practice that can improve present moment awareness. When applied as therapeutic intervention mindfulness meditation can help patients to stay with their attention in the present moment, to be aware what is happening in the here and now, and to better identify and regulate upcoming emotions. The current observational study investigates changes in symptom severity and mindfulness skills during DBT treatment. A treatment group will be compared to a waitlist control group. The two groups are predefined by routine medical care. Symptom severity and mindfulness skills will be assessed at baseline (before treatment or when accepted for the waitlist) and after 12-weeks. A within and between group analyses will be performed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Dialectical Behavioural Therapy (DBT) | Inpatient Dialectical Behavioural Therapy (DBT) according to Linehan. |
Timeline
- Start date
- 2017-05-04
- Primary completion
- 2017-11-01
- Completion
- 2017-12-01
- First posted
- 2017-09-29
- Last updated
- 2017-09-29
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03297840. Inclusion in this directory is not an endorsement.